Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MDA autologous tumor-infiltrating lymphocytes |
Trade Name | |
Synonyms | MDA-TILs|Autologous MDA TILs |
Drug Descriptions |
MDA autologous tumor-infiltrating lymphocytes are patient-derived T-lymphocytes expanded with interleukin-2 (IL-2) and a CD137 (4-1BB) agonistic antibody, and then reintroduced, which potentially results in tumor cell killing (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C153312 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Aldesleukin + Cyclophosphamide + Fludarabine + MDA autologous tumor-infiltrating lymphocytes | Aldesleukin Cyclophosphamide Fludarabine MDA autologous tumor-infiltrating lymphocytes | 0 | 1 |
MDA autologous tumor-infiltrating lymphocytes | MDA autologous tumor-infiltrating lymphocytes | 0 | 0 |